 |
|
|
|
|
 |
Last Updated: Sep 8, 2007 - 1:21:03 PM |
Latest Research
:
Genetics
:
Genetic Disorders
:
Progeria
Farnesyl Transferase Inhibitors in Hutchinson-Gilford progeria syndrome
Johns Hopkins scientists have discovered that a drug currently being tested against cancers might help children with a rare, fatal condition called Hutchinson-Gilford progeria syndrome, which causes rapid, premature aging.
Children with progeria appear normal until they're 6 months to a year old, but then begin developing symptoms normally associated with old age -- wrinkled skin, hair loss, brittle bones and atherosclerosis, which usually causes their deaths by about age 13. There's no known treatment.
Sep 28, 2005 - 1:20:00 PM
|
Latest Research
:
Genetics
:
Genetic Disorders
:
Progeria
Anti-cancer drugs might work in aging disease
Working together, scientists at the National Institutes of Health and the University of North Carolina at Chapel Hill have developed a promising new strategy for treating a form of progeria. That rare but deadly and heartbreaking genetic disease causes children to age remarkably fast and die almost always before they complete their teens.
Aug 30, 2005 - 7:45:00 PM
|
Latest Research
:
Genetics
:
Genetic Disorders
:
Progeria
Lamin research project provides clues about premature aging
A step towards understanding cell mutations that cause a variety of human diseases, particularly in children -- including that which brings about premature aging and early death -- has been taken by researchers at the Hebrew University of Jerusalem Silberman Institute of Life Sciences and the John Hopkins University School of Medicine.
Aug 30, 2005 - 7:42:00 PM
|
Latest Research
:
Genetics
:
Genetic Disorders
:
Progeria
Drug prevents cell abnormality leading to progeria
Genetic disease causes accelerated aging, death in children
Aug 30, 2005 - 7:39:00 PM
|
Latest Research
:
Genetics
:
Genetic Disorders
:
Progeria
Farnesyltransferase inhibitors (FTIs) might be useful in Hutchinson-Gilford Progeria Syndrome
In a surprising development, a research team led by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), has found that a class of experimental anti-cancer drugs also shows promise in laboratory studies for treating a fatal genetic disorder that causes premature aging.
Aug 30, 2005 - 7:33:00 PM
|
<< prev
next >>
|
|
|
|
